Postmenopausal hormone replacement therapy and risk of acute pancreatitis: A population-based case-control study

American Journal of Gastroenterology

Volumn 102, Issue 2, 2007, Pages 275-278

  Tetsche, Mette S ^a,b,e   Jacobsen, Jacob ^a   Nørgaard, Mette ^a   Baron, John A ^c   Sørensen, Henrik T ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d BOSTON UNIVERSITY   (United States)

^e NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN;

ACUTE PANCREATITIS; ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HOSPITAL DISCHARGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE;

CONFIDENCE INTERVALS; DENMARK; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; PANCREATITIS, ACUTE NECROTIZING; POPULATION SURVEILLANCE; POSTMENOPAUSE; PROGESTINS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33846518790     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00924.x     Document Type: Article

References (21)

1. Bank S, Marks IN. Hyperlipaemic pancreatitis and the pill. Postgrad Med J 1970;46:576-8.
2. Blake WE, Pitcher ME. Estrogen-related pancreatitis in the setting of normal plasma lipids: Case report. Menopause 2003;10:99-101.
3. Glueck CJ, Scheel D, Fishback J, et al. Estrogen-induced pancreatitis in patients with previously covert familial type V hyperlipoproteinemia. Metabolism 1972;21:657-66.
4. Glueck CJ, Lang J, Hamer T, et al. Severe hypertriglyceridemia and pancreatitis when estrogen replacement therapy is given to hypertriglyceridemicwomen. J Lab Clin Med 1994;123:59-64.
5. Isley WL, Oki J. Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy. Am J Med 1997;102:416-7.
6. Ruman J, Brenner S, Sauer MV. Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer. J Assist Reprod Genet 2002;19:94-7.
7. Davidoff F, Tishler S, Rosoff C. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. N Engl J Med 1973;289:552-5.
8. Mungall IP, Hague RV. Pancreatitis and the pill. Postgrad Med J 1975;51:855-7.
9. Parker WA. Estrogen-induced pancreatitis. Clin Pharm 1983;2:75-9.
10. Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: An update. J Clin Gastroenterol 2005;39:709-16.
11. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
12. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
13. Szklo M, Nieto FJ. Epidemiology beyond the basics, 1st Ed. Gaithersburg, MA: Aspen Publishers, 2000.
14. Goldenberg NM, Wang P, Glueck CJ. An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia. Clin Chim Acta 2003;332:11-9.
15. Granfone A, Campos H, McNamara JR, et al. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism 1992;41:1193-8.
16. Floyd A, Pedersen L, Nielsen GL, et al. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: A register-based study from 1981-2000. Scand J Gastroenterol 2002;37:1461-5.
17. Jick H, Garcia Rodriguez LA, Perez-Gutthann S. Principles of epidemiological research on adverse and beneficial drug effects. Lancet 1998;352:1767-70.
18. Weinstock MA, Colditz GA, Willett WC, et al. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol 1991;133:240-5.
19. Shmuely Y, Berlin JA, Knauss J, et al. Compliance with oral HRT in postmenopausal women in clinical trials - meta analysis. Maturitas 2003;46:33-44.
20. Lokkegaard EL, Johnsen SP, Heitmann BL, et al. The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand 2004;83:476-81.
21. Olesen AV, Johnsen SP, Mortensen JT, et al. Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women. Acta Obstet Gynecol Scand 2005;84:639-44.